ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,573Medicare Part D Prescriptions Filled, Including Refills

Rank: 351 out of 1456

$593K Total Retail Price of All Prescriptions

Rank: 343 out of 1456

443 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 443 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

7% of this provider’s 443 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 8,835 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
LEVOTHYROXINE SODIUM 564 449 1 4
PRAVASTATIN SODIUM 510 414 2 9
LISINOPRIL 378 330 3 3
OMEPRAZOLE 343 290 4 5
AMLODIPINE BESYLATE 333 295 5 1
FUROSEMIDE 266 222 6 7
CARVEDILOL 241 194 7 20
HYDROCHLOROTHIAZIDE 223 194 8 10
ATENOLOL 203 190 9 18
DOXAZOSIN MESYLATE 194 186 10 84
ATORVASTATIN CALCIUM 182 173 11 11
GLIMEPIRIDE 179 128 12 33
TRAMADOL HCL 170 134 13 17
METFORMIN HCL ER 168 139 14 54
MELOXICAM 167 134 15 30
CLONIDINE HCL 164 139 16 39
METOPROLOL TARTRATE 148 135 17 12
LOSARTAN POTASSIUM 139 104 18 16
DIOVAN 129 104 19 35
CITALOPRAM HBR 123 95 20 22
DONEPEZIL HCL 111 104 21 29
GABAPENTIN 105 92 22 13
JANUVIA 104 79 23 68
CRESTOR 99 85 24 26
HYDROCODONE-ACETAMINOPHEN 97 76 S3 25 6
DIGOXIN 89 76 26 62
FLUTICASONE PROPIONATE 86 76 27 28
CLOPIDOGREL 83 74 28 32
TRIAMTERENE-HCTZ 78 52 29 49
WARFARIN SODIUM 77 75 30 21
PANTOPRAZOLE SODIUM 77 71 30 43
MORPHINE SULFATE 76 72 S2 32 287
SPIRIVA 76 55 32 75
ALLOPURINOL 76 73 32 31
SERTRALINE HCL 76 64 32 25
LOSARTAN-HYDROCHLOROTHIAZIDE 73 59 36 41
ISOSORBIDE MONONITRATE ER 72 69 37 60
ZOLPIDEM TARTRATE 72 65 37 14
METOPROLOL SUCCINATE 71 70 39 19
BISOPROLOL FUMARATE 69 68 40 208
METFORMIN HCL 68 59 41 8
AMLODIPINE BESYLATE-BENAZEPRIL 66 52 42 61
TRICOR 63 47 43 92
KLOR-CON M20 62 44 44 51
LANTUS SOLOSTAR 61 59 45 120
NEXIUM 61 29 45 23
LANTUS 61 61 45 50
CYCLOBENZAPRINE HCL 61 40 R 45 66
NAMENDA 60 60 49 38
AZITHROMYCIN 59 42 50 44
CELEBREX 58 48 51 88
DIOVAN HCT 58 47 51 59
FENOFIBRATE 56 49 53 56
POTASSIUM CHLORIDE 54 43 54 15
BUSPIRONE HCL 53 44 55 151
LIPITOR 52 48 56 76
PAROXETINE HCL 50 47 57 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 11, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.